Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
November 06, 2017 08:30 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Fibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 Financial Results and Recent Operational Highlights
November 06, 2017 08:00 ET
|
Fibrocell Science Inc
EXTON, Pa., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
RedHill Biopharma Announces EnteraGam® Poster Presentation at the ISPOR 20th Annual European Congress
November 06, 2017 07:00 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 06, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical...
Horizon Pharma plc Announces Third-Quarter and Year-to-Date 2017 Results
November 06, 2017 07:00 ET
|
Horizon Pharma plc
-- Third-Quarter 2017 Net Sales of $271.6 Million -- -- Third-Quarter 2017 Net Loss of $64.0 Million; Adjusted EBITDA of $108.1 Million -- -- Third-Quarter 2017 GAAP Operating Cash Flow of $68.3...
Anthera Pharmaceuticals Announces Presentation of Blisibimod Data at the American College of Rheumatology Annual Meeting
November 05, 2017 08:30 ET
|
Anthera Pharmaceuticals, Inc.
HAYWARD, Calif., Nov. 05, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) will present additional findings from the CHABLIS-SC1, Phase 3 clinical study of blisibimod, a novel...
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clinical Trials on Alzheimer’s Disease Meeting
November 04, 2017 15:30 ET
|
Anavex Life Sciences Corp.
Presentation Includes New Data from Phase 2a Long-Term Extension Cohort NEW YORK, Nov. 04, 2017 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company) (Nasdaq:AVXL), a...
Apricus Biosciences Provides Corporate Update and Third Quarter 2017 Financial Results
November 02, 2017 16:01 ET
|
Apricus Biosciences, Inc.
Vitaros U.S. NDA Resubmission Review Remains on TrackPDUFA Goal Date of February 17, 2018 Conference Call / Webcast Today, November 2, 2017 at 4:30 p.m. ET SAN DIEGO, Calif., Nov. 02, 2017 (GLOBE...
Arbutus Announces Corporate Update and Third Quarter 2017 Financial Results
November 02, 2017 16:00 ET
|
Arbutus Biopharma Corporation
Strategic Investment from Roivant Extends Cash RunwayCombination Study for ARB-1467 Starting in 4Q17Company to Host a Corporate Update Conference Call Today at 4:15 PM ET VANCOUVER, British Columbia...
Anthera Pharmaceuticals Announces Presentations of Sollpura Data at the North American Cystic Fibrosis Conference
November 02, 2017 08:30 ET
|
Anthera Pharmaceuticals, Inc.
HAYWARD, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that data from the SOLUTION, Phase 3 clinical study of Sollpura (liprotamase) and an...
NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program
November 02, 2017 08:00 ET
|
NewLink Genetics Corporation
AMES, Iowa, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the third quarter of 2017 and provided updates on its...